<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="766">
  <stage>Registered</stage>
  <submitdate>19/09/2005</submitdate>
  <approvaldate>9/11/2005</approvaldate>
  <actrnumber>ACTRN12605000722695</actrnumber>
  <trial_identification>
    <studytitle>A randomised clinical trial of interpersonal social rhythms psychotherapy in young people with bipolar disorder.</studytitle>
    <scientifictitle>A randomised clinical trial of interpersonal social rhythms therapy with non-specific supportive clinical management in the treatment of young people with bipolar disorder to reduce the cummulative burden of depressive symptomatology over the period from 6 to 18 months after starting treatment.</scientifictitle>
    <utrn />
    <trialacronym>PBS</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Bipolar disorder</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Interpersonal social rhythms psychotherapy (IPSRT).
Duration: 18 months.</interventions>
    <comparator>Non-specific Supportive Clinical Management (NSCM).
Duration: 18 months.</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To evaluate the hypothesis that Interpersonal Social Rhythms Psychotherapy (IPSRT) is superior to a "control" psychological intervention (non-specific supportive clinical management (NSCM), in improving the medium term (6-18 month) outcome of young people with bipolar disaffective disorder, who are also receiving psychopharmacological treatment.</outcome>
      <timepoint>Analysis will be completed following the 18 month treatment protocol.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Primary outcome is decreased cumulative burden of depressive symptoms.</outcome>
      <timepoint>Analysis will be completed following the 18 month treatment protocol.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>1. Improved social functioning</outcome>
      <timepoint>Analysis will be completed following the 18 month treatment protocol.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>2. Decreased manic/hypomanic cumulative burden.</outcome>
      <timepoint>Analysis will be completed following the 18 month treatment protocol.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>(a) able and willing to sign informed consent for the research protocol. Patients may be on any medication, or combination of medication when they enter the study.</inclusivecriteria>
    <inclusiveminage>15</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>(a) schizophrenia or schizoaffective disorder; (b) severe alcohol or drug dependence as a principal diagnosis; (c) low probability of remaining in contact with treating clinicians.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes.</concealment>
    <sequence>Computer generated permutated block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/10/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Health Research Council of New Zealand</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council of New Zealand</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Christchurch</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Peter Joyce</name>
      <address>Department of Psychological Medicine
Christchurch School of Medicine &amp; Health Sciences
PO Box 4345
Christchurch 8001</address>
      <phone>+64 3 3720400</phone>
      <fax>+64 3 3720407</fax>
      <email>peter.joyce@chmeds.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Peter Joyce</name>
      <address>Department of Psychological Medicine
Christchurch School of Medicine &amp; Health Sciences
PO Box 4345
Christchurch 8001</address>
      <phone>+64 3 3720400</phone>
      <fax>+64 3 3720407</fax>
      <email>peter.joyce@chmeds.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>